DadFinStart your free week
DadFin › Stocks › Technology › PSN

Parsons Corporation (PSN) stock score

Technology · Information Technology Services · United States

$45.08 ▲ +4.79% today

52.3
Dad Score, out of 100
middling

Parsons Corporation (PSN) is a Information Technology Services company in the Technology sector, listed in the United States. On DadFin's weekly run it scores 52.3 out of 100 on the Dad Score, a middling reading that places the business ahead of 52% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Technology it ranks #363 of 780. Its strongest axes are valuation and conviction; its weakest are growth and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Average
Growth
Weak
Price action
Average
Risk
Weak
Conviction
Above average
Liquidity
Average
Macro
Weak

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)28.1×
P/E (forward)11.9×
Dividend yield0.00%
Return on capital8.6%
Operating margin2.2%
Revenue growth (YoY)-5.7%
FCF yield7.8%
Net debt / EBITDA2.93×
Piotroski F-Score5 / 9
52-week change-53.8%
Market cap$4.4B
Next earningsNov 4, 2026

What subscribers see on PSN

Start your free weekSubscriber? Open the full research →

Information Technology Services peers

StockCompanyDad ScoreBandMarket cap
IBMInternational Business Machines Co69.6middling$209.8B
ACNAccenture plc93.3strong$121.7B
INFYInfosys Limited51.8middling$44.7B
CTSHCognizant Technology Solutions Cor64.9middling$27.7B
BRBroadridge Financial Solutions, In74.9good$17.7B
WITWipro Limited32.7weak$17.0B
FISFidelity National Information Serv54.3middling$16.8B
CDWCDW Corporation87.7strong$16.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.